Swiss National Bank - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 204 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$21,648,000
+5.1%
143,200
+1.3%
0.02%
+7.1%
Q2 2022$20,589,000
+24.6%
141,300
+1.4%
0.01%
+55.6%
Q1 2022$16,529,000
-7.5%
139,400
+7.6%
0.01%
-18.2%
Q4 2021$17,860,000
-0.6%
129,600
+0.2%
0.01%0.0%
Q3 2021$17,975,000
+55.7%
129,400
+8.8%
0.01%
+57.1%
Q2 2021$11,543,000
+45.0%
118,900
+2.1%
0.01%
+40.0%
Q1 2021$7,963,000
-19.0%
116,500
+1.6%
0.01%
-28.6%
Q4 2020$9,831,000
+34.1%
114,700
+1.7%
0.01%
+16.7%
Q3 2020$7,333,000
-9.3%
112,800
+2.0%
0.01%
-14.3%
Q2 2020$8,086,000
+176.3%
110,600
+28.6%
0.01%
+133.3%
Q1 2020$2,927,000
-36.6%
86,000
+1.4%
0.00%
-40.0%
Q4 2019$4,617,000
+34.6%
84,800
+3.2%
0.01%
+25.0%
Q3 2019$3,429,000
-3.9%
82,200
+0.9%
0.00%0.0%
Q2 2019$3,569,000
+88.4%
81,500
+121.5%
0.00%
+100.0%
Q1 2019$1,894,000
+44.2%
36,800
+3.7%
0.00%0.0%
Q4 2018$1,313,000
+3.1%
35,500
+4.7%
0.00%
+100.0%
Q3 2018$1,273,000
+2.9%
33,900
+8.3%
0.00%0.0%
Q2 2018$1,237,000
+53.5%
31,3000.0%0.00%0.0%
Q1 2018$806,000
+95.2%
31,300
+104.6%
0.00%
Q4 2017$413,00015,3000.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders